|
About Us - Intellectual Property
ChromaDex is a licensee of two U.S. patents from the USDA-ARS and the University of Mississippi and is working on the third patent with a strategic partner.
- Patent Pending #1: "Pterostilbene as a New Agonist for the Peroxisome Proliferator-Activated Receptor Alpha Isoform."
- Patent Pending #2: "Method to Ameliorate Oxidative Stress and Improve Working Memory via Pterostilbene Administration."
- Patent Pending #3: "A Key Intermediate for the Preparation of Stilbenes"
All pterostilbene products developed by ChromaDex, such as pTeroPure, will be based on the technologies licensed from the USDA ARS and the University of Mississippi. |